Incidence, epidemiological characteristics and factors associated with COVID-19 pneumonia among inmates, Phetchabun Province, Thailand

Authors

  • Tassana Thammaros Phetchabun Hospital

DOI:

https://doi.org/10.14456/dcj.2023.56

Keywords:

incidence, epidemiological characteristic, associated factors, COVID-19, prison

Abstract

This study aimed to assess incidence, describe epidemiological characteristics, and identify factors associated with COVID-19 pneumonia among inmates in the prison in Phetchabun Province, Thailand (prison A). This was a retrospective cohort study. The population in this study were inmates in prison A who were COVID-19 patients during August 1st to October 31st, 2021. The data were gathered by reviewing medical record. The variables were age, sex, weight, height, underlying conditions, onset date, date of receiving antiviral medication, and chest x-ray results. The data were quantified as the frequency, percentage, mean, median, minimum, maximum, and standard deviation. Data were further analyzed using chi-square test, Fisher exact test, and binary logistic regression. A p-value less than 0.05 was a statistically significant. The findings revealed the incidence of COVID pneumonia was 17.6% (280/1590). Female: male ratio was 1: 69. The mean±SD of age was 34.8±10.3 years: minimum 18 years and maximum 81 years. Most of patients had weight less than 90 kg and normal body mass index. The multivariate analysis illustrated that male (adjusted odds ratio (AOR)=8.8, 95% confidence interval (95% CI)=3.2-24.1, p-value<0.001), age≥ 60 years old (AOR=4.4, 95% CI=2.3-8.3, p-value<0.001), and patients with tuberculosis (AOR=3.1, 95% CI=1.8-5.5, p value<0.001) showed the statistical significance. Even though, the number of COVID-19 patients was high, incidence and mortality were lower than prior studies. It might be the result of favipiravir treatment in all patients. Moreover, the average age of patient was quite young, and might be healthy. The effectiveness of favipiravir should study further.

References

World Health Organization. Coronavirus disease (COVID-19) [Internet]. [cited 2022 Jun 27]. Available from: https://www.who.int/health-topics/coronavirus#tab=tab_1

World Health Organization. WHO Coronavirus (COVID-19) Dashboard [Internet]. [cited 2022 Jun 28]. Available from: https://covid19.who.int/

Department of Disease Control (TH). The daily updated of COVID-19 infection situation [Internet]. [cited 2022 Jun 28]. Available from: https://ddc.moph.go.th/covid19-dashboard/ (in Thai)

The International Committee of the Red Cross (TH). The preventing and coping guideline for coronavirus disease (COVID-19) in the prison, Thailand [Internet]. 2022 [cited 2022 Jun 29]. Available from: https://ddc.moph.go.th/viralpneumonia/file/introduction/introduction24.pdf (in Thai)

Marquez N, Ward JA, Parish K, Saloner B, Dolovich S. COVID-19 incidence and mortality in federal and state prisons compared with the US population, April 5, 2020, to April 3, 2021. JAMA. 2021;326(18):1865-7.

Royal Thai Government (TH). The situation of COVID-19 in prisons 2022 [Internet]. 2022 [cited 2022 Jun 30]. Available from: https://www.thaigov.go.th/news/contents/details/53521

Sirijatuphat R, Suputtamongkol Y, Angkasekwinai N, Horthongkham N, Chayakulkeeree M, Rattanaumpawan P, et al. Epidemiology, clinical characteristics, and treatment outcomes of patients with COVID-19 at Thailand’s university-based referral hospital. BMC Infectious Diseases. 2021;21(1):382.

Özger HS, Aysert Yıldız P, Gaygısız Ü, Uğraş Dikmen A, Demirbaş Gülmez Z, Yıldız M, et al. The factors predicting pneumonia in COVID-19 patients: preliminary results from a university hospital in Turkey. Turk J Med Sci. 2020;50 (8):1810-6.

Dean AG, Sullivan KM, Soe MM. Open source epidemiologic statistics for public health [Internet]. 2013 [cited 2022 Jun 29]. Available from: https://www.openepi.com/SampleSize/SSCohort.htm

Department of Medical Services (TH). Clinical practice guideline for COVID-19 [Internet]. [cited 2022 Jun 30]. Available from: https://covid19.dms.go.th/ (in Thai)

Patipanwat P. Factors of affecting fatality with COVID-19 patients in Kalasin Hospital. Journal of Health and Environmental Education. 2022;7(1):64-71. (in Thai)

Leibowitz AI, Siedner MJ, Tsai AC, Mohareb AM. Association between prison crowding and COVID-19 incidence rates in Massachusetts Prisons, April 2020-January 2021. JAMA Internal Medicine. 2021;181(10):1315-21.

Medical Correctional Hospital (TH). How comfortable to sleep in prison [Internet]. [cited 2022 Dec 20]. Available from: https://www.hosdoc.com/index.php?option=com_content&view=article&id=40:how-comfortable-to- sleep-in-prison&catid=2:guide-prison (in Thai)

Niyomwan N, Jarujittipant P. Crisis management of prisoners custody in Thailand. Journal of MCU Peace Studies. 2018;6(3):1159-70.

Thammaros T, Simkum T, Kanthu A. The investigation of a scabies outbreak at a prison in Phetchabun Province, Thailand, November 2019. Weekly Epidemiological Surveillance Report. 2020;51:273-9.

U.S. Environmental Protection Agency (US). Indoor air and coronavirus (COVID-19) [Internet]. [cited 2023 Feb 11]. Available from: https://www.epa.gov/coronavirus/indoor -air-and-coronavirus-covid-19

Pongpirul WA, Wiboonchutikul S, Charoenpong L, Panitantum N, Vachiraphan A, Uttayamakul S, et al. Clinical course and potential predictive factors for pneumonia of adult patients with coronavirus disease 2019 (COVID-19): A retrospective observational analysis of 193 confirmed cases in Thailand. PLoS Negl Trop Dis. 2020;14(10):e0008806.

Sirijatuphat R, Manosuthi W, Niyomnaitham S, Owen A, Copeland KK, Charoenpong L, et al. Early treatment of favipiravir in COVID-19

patients without pneumonia: a multicentre, open -labelled, randomized control study. Emerg Microbes Infect. 2022;11(1):2197-206.

Doi Y, Hibino M, Hase R, Yamamoto M, Kasamatsu Y, Hirose M, et al. A prospective, randomized, open-label trial of early versus late favipiravir therapy in hospitalized patients with COVID-19. Antimicrob Agents Chemother. 2020;64(12):e01897-20.

Karatas E, Aksoy L, Ozaslan E. Association of early favipiravir use with reduced COVID-19 fatality among hospitalized patients. Infect Chemother. 2021;53(2):300-7.

Manabe T, Kambayashi D, Akatsu H, Kudo K. Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis. BMC Infect Dis. 2021;21(1):489.

Zsichla L, Muller V. Risk Factors of Severe COVID-19: A review of host, viral and environmental factors. Viruses. 2023;15(1):175.

Department of Medical Services (TH). Clinical practice guidelines for COVID-19 [Internet]. [cited 2023 Feb 12]. Available from: https://covid19.dms.go.th/backend/Content/Content_FIle/Bandner_(Big)/Attach/25650929 162845PM_25650929131357PM_CPG_COVID-19_v.25_n_20220929.pdf (in Thai)

Wu C, Chen X, Cai Y, Xia Ja, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Internal Medicine. 2020;180(7) :934-43.

Fabião J, Sassi B, Pedrollo EF, Gerchman F, Kramer CK, Leitão CB, et al. Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age. Braz J Med Biol Res. 2022;55:e11711.

Banfi P, Garuti G, Diaz DETT, Ruiz J, Ferraioli G, Russo G, et al. Differences between sexes concerning COVID-19-related pneumonia. Panminerva Med. 2022;64(4):517-24.

Beltrame A, Salguero P, Rossi E, Conesa A, Moro L, Bettini LR, et al. Association between sex hormone levels and clinical outcomes in patients with COVID-19 admitted to hospital: An Observational, Retrospective, Cohort Study. Front Immunol. 2022;13:834851.

Downloads

Published

2023-12-29

How to Cite

1.
Thammaros T. Incidence, epidemiological characteristics and factors associated with COVID-19 pneumonia among inmates, Phetchabun Province, Thailand. Dis Control J [Internet]. 2023 Dec. 29 [cited 2024 Apr. 15];49(4):685-93. Available from: https://he01.tci-thaijo.org/index.php/DCJ/article/view/261677

Issue

Section

Original Article